Acadia Pharma (ACAD) Hits New 52-Week High on Volume Over Key Resistance Level
Get Alerts ACAD Hot Sheet
Join SI Premium – FREE
Acadia Pharmaceuticals, Inc. (Nasdaq: ACAD) is showing some unusually strong volume Friday as shares pop to a new annual high.
Currently, about 4.6 million shares have traded compared with the daily average that is just below 1 million.
Causing the increased volume is ACADIA moving above the $2.80 level. That level was largely a resistance point for the pharma in September, which shares were parabolic.
With the exception of a spike higher in April 2011, this is the first time ACADIA has been back above $3 since September 2009.
The stock is currently up 1.5 percent on the session.
Currently, about 4.6 million shares have traded compared with the daily average that is just below 1 million.
Causing the increased volume is ACADIA moving above the $2.80 level. That level was largely a resistance point for the pharma in September, which shares were parabolic.
With the exception of a spike higher in April 2011, this is the first time ACADIA has been back above $3 since September 2009.
The stock is currently up 1.5 percent on the session.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- IBM tumbles on soft Q1 revenue; announces HashiCorp $6.4bn acquisition
- Acadia Pharmaceuticals to Announce First Quarter Financial Results on May 8, 2024
- 'ArcaneDoor' Cyberspies Hacked Cisco (CSCO) Firewalls to Access Government Networks - Wired
Create E-mail Alert Related Categories
Technicals, Trader TalkSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!